ArticleRSC advances2022

Development of a novel chemoenzymatic route to enantiomerically enriched β-adrenolytic agents. A case study toward propranolol, alprenolol, pindolol, carazolol, moprolol, and metoprolol.

Paweł Borowiecki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.